ONNIX adds former Sen. Mark Begich to board

By AI, Created 12:10 PM UTC, May 22, 2026, /AGP/ – ONNIX named former U.S. Sen. and Anchorage Mayor Mark Begich to its board of directors as the medical technology company advances catheter care and vascular access products. The appointment brings government, economic development and coalition-building experience to ONNIX as it moves through clinical development, regulatory review and commercialization.

Why it matters: - ONNIX is pushing catheter care and vascular access technologies toward clinical and commercial milestones. - Begich brings federal, municipal and business-network experience that could help ONNIX navigate healthcare adoption, regulation and stakeholder alignment. - The appointment signals a focus on governance and external engagement as the company scales.

What happened: - ONNIX announced that former U.S. Sen. Mark Begich joined its board of directors. - Begich represented Alaska in the U.S. Senate from 2009 to 2015. - Begich also served two terms as mayor of Anchorage from 2003 to 2009. - ONNIX is based in the medical technology sector and focuses on vascular access and catheter care.

The details: - ONNIX is developing catheter care technologies, including catheter lock and flush technology designed to support safer vascular access care. - The company said its mission centers on practical, science-driven innovation aimed at patient safety, workflow efficiency and stronger clinical outcomes. - CEO Jared Navarre said Begich brings leadership experience, strategic insight and experience navigating complex systems. - Begich said he is joining ONNIX at a pivotal stage as the company advances its core catheter-care technology in a complex healthcare environment. - Begich pointed to adoption factors that include clinical performance, workflow fit, provider economics, institutional buying decisions, reimbursement and measurable improvements in patient care. - As a board member, Begich will support governance, strategy and external engagement. - ONNIX said the appointment reflects its emphasis on experienced leadership, disciplined oversight and practical execution.

Between the lines: - The hire suggests ONNIX wants board-level help that extends beyond medtech expertise into policy, economic development and institutional decision-making. - Begich’s background may be especially useful if ONNIX needs to build trust with providers, health systems and other stakeholders before launch. - The company is framing commercialization as both a clinical and business challenge, not just a product-development exercise.

What’s next: - ONNIX will continue moving through clinical development, regulatory review and commercial launch. - Begich is expected to help guide the company’s clinical and commercial roadmap. - ONNIX’s next stage will likely depend on how its catheter-care technology performs in clinical settings and fits into provider workflows. - More information about ONNIX or the announcement is available from the company contact.